{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:27:30Z","timestamp":1792106850082,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-024-03415-5","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:17:06Z","timestamp":1730107026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuanyuan","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"1","key":"3415_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu X, Peng Q, Wang G. Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat Rev Rheumatol. 2024;20(1):48\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"3415_CR2","doi-asserted-by":"publisher","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","volume":"12","author":"A Nombel","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F. Dermatomyositis with Anti-MDA5 antibodies: Bioclinical Features, Pathogenesis and emerging therapies. Front Immunol. 2021;12:773352.","journal-title":"Front Immunol"},{"issue":"11","key":"3415_CR3","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1093\/rheumatology\/keac094","volume":"61","author":"J So","year":"2022","unstructured":"So J, So H, Wong VT, Ho R, Wu TY, Wong PC, et al. Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis. Rheumatology (Oxford). 2022;61(11):4437\u201344.","journal-title":"Rheumatology (Oxford)"},{"key":"3415_CR4","doi-asserted-by":"publisher","first-page":"2024869","DOI":"10.1155\/2020\/2024869","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y, Li Y, Wu J, Miao M, Gao X, Cai W, et al. Predictors of poor outcome of Anti-MDA5-Associated rapidly progressive interstitial lung disease in a Chinese cohort with Dermatomyositis. J Immunol Res. 2020;2020:2024869.","journal-title":"J Immunol Res"},{"issue":"4","key":"3415_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 2011;147(4):391\u20138.","journal-title":"Arch Dermatol"},{"issue":"12","key":"3415_CR6","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1007\/s00296-011-2323-y","volume":"32","author":"F Chen","year":"2012","unstructured":"Chen F, Wang D, Shu X, Nakashima R, Wang G. Anti-MDA5 antibody is associated with A\/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol Int. 2012;32(12):3909\u201315.","journal-title":"Rheumatol Int"},{"issue":"7","key":"3415_CR7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","volume":"51","author":"T Koga","year":"2012","unstructured":"Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford). 2012;51(7):1278\u201384.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3415_CR8","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/rheumatology\/keac450","volume":"62","author":"H You","year":"2023","unstructured":"You H, Wang L, Wang J, Lv C, Xu L, Yuan F, et al. Time-dependent changes in RPILD and mortality risk in anti-MDA5\u2009+\u2009DM patients: a cohort study of 272 cases in China. Rheumatology (Oxford). 2023;62(3):1216\u201326.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3415_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/joim.13607","volume":"293","author":"Q Jin","year":"2023","unstructured":"Jin Q, Fu L, Yang H, Chen X, Lin S, Huang Z, et al. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis. J Intern Med. 2023;293(4):494\u2013507.","journal-title":"J Intern Med"},{"issue":"2","key":"3415_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/rheumatology\/keab371","volume":"61","author":"T Gono","year":"2022","unstructured":"Gono T, Okazaki Y, Kuwana M. Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease. Rheumatology (Oxford). 2022;61(2):806\u201314.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3415_CR11","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/rheumatology\/keac627","volume":"62","author":"M Kogami","year":"2023","unstructured":"Kogami M, Abe Y, Ando T, Makiyama A, Yamaji K, Tamura N. Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2023;62(7):2525\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3415_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjd.14882","volume":"176","author":"T Matsushita","year":"2017","unstructured":"Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, et al. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol. 2017;176(2):395\u2013402.","journal-title":"Br J Dermatol"},{"issue":"9","key":"3415_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2012;51(9):1563\u201370.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3415_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.55563\/clinexprheumatol\/zmn18h","volume":"40","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Wang L, Sun Y, Wang J, Lv C, You H, et al. Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease. Clin Exp Rheumatol. 2022;40(2):292\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"3415_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.41566","volume":"73","author":"T Gono","year":"2021","unstructured":"Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K, et al. Risk prediction modeling based on a combination of initial serum biomarker levels in Polymyositis\/Dermatomyositis-Associated interstitial lung disease. Arthritis Rheumatol. 2021;73(4):677\u201386.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"3415_CR16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s10067-019-04457-w","volume":"38","author":"L Jiang","year":"2019","unstructured":"Jiang L, Wang Y, Peng Q, Shu X, Wang G, Wu X. Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody. Clin Rheumatol. 2019;38(6):1655\u201363.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3415_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/crj.13616","volume":"17","author":"Y Li","year":"2023","unstructured":"Li Y, Liu X, Tian M, Zou R, Gao Y, Huang M, et al. Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti-MDA5 antibody-positive dermatomyositis related interstitial lung disease. Clin Respir J. 2023;17(6):507\u201315.","journal-title":"Clin Respir J"},{"key":"3415_CR18","doi-asserted-by":"publisher","first-page":"628128","DOI":"10.3389\/fcell.2021.628128","volume":"9","author":"L Liang","year":"2021","unstructured":"Liang L, Zhang YM, Shen YW, Song AP, Li WL, Ye LF, et al. Aberrantly expressed Galectin-9 is involved in the immunopathogenesis of Anti-MDA5-Positive Dermatomyositis-Associated interstitial lung disease. Front Cell Dev Biol. 2021;9:628128.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3415_CR19","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/bjd.16917","volume":"180","author":"SH Zhang","year":"2019","unstructured":"Zhang SH, Zhao Y, Xie QB, Jiang Y, Wu YK, Yan B. Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis. Br J Dermatol. 2019;180(5):1090\u20138.","journal-title":"Br J Dermatol"},{"issue":"3","key":"3415_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10067-020-05339-2","volume":"40","author":"J Bai","year":"2021","unstructured":"Bai J, Wu C, Zhong D, Xu D, Wang Q, Zeng X. Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis. Clin Rheumatol. 2021;40(3):999\u20131008.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"3415_CR21","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1093\/rheumatology\/keaa123","volume":"59","author":"M Shirakashi","year":"2020","unstructured":"Shirakashi M, Nakashima R, Tsuji H, Tanizawa K, Handa T, Hosono Y, et al. Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment. Rheumatology (Oxford). 2020;59(11):3284\u201392.","journal-title":"Rheumatology (Oxford)"},{"key":"3415_CR22","doi-asserted-by":"publisher","first-page":"745211","DOI":"10.3389\/fimmu.2021.745211","volume":"12","author":"J Liang","year":"2021","unstructured":"Liang J, Cao H, Wu B, Liu Y, He Y, Xu B, et al. Clinical value of (18)F-FDG PET\/CT scan and cytokine profiles in secondary hemophagocytic lymphohistiocytosis in idiopathic inflammatory myopathy patients: a pilot study. Front Immunol. 2021;12:745211.","journal-title":"Front Immunol"},{"issue":"1","key":"3415_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","volume":"35","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yang CS, Li YJ, Liu XD, Wang JN, Zhao Q, et al. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Clin Rheumatol. 2016;35(1):113\u20136.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"3415_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43556-020-00015-y","volume":"2","author":"Y Ni","year":"2021","unstructured":"Ni Y, Alu A, Lei H, Wang Y, Wu M, Wei X. Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19. Mol Biomed. 2021;2(1):1.","journal-title":"Mol Biomed"},{"issue":"6","key":"3415_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/infdis\/jiv380","volume":"213","author":"H Chu","year":"2016","unstructured":"Chu H, Zhou J, Wong BH, Li C, Chan JF, Cheng ZS, et al. Middle East Respiratory Syndrome Coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016;213(6):904\u201314.","journal-title":"J Infect Dis"},{"key":"3415_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119.","journal-title":"Front Immunol"},{"issue":"2","key":"3415_CR27","first-page":"269","volume":"42","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang P, Yang Q, Zhang C, Guan W, Liu S. Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome. Clin Exp Rheumatol. 2024;42(2):269\u201376.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"3415_CR28","doi-asserted-by":"publisher","first-page":"103114","DOI":"10.1016\/j.autrev.2022.103114","volume":"21","author":"P Ruscitti","year":"2022","unstructured":"Ruscitti P, Di Cola I, Di Muzio C, Italiano N, Ursini F, Giacomelli R, et al. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications. Autoimmun Rev. 2022;21(7):103114.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"3415_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3109\/14397595.2013.844390","volume":"24","author":"M Nara","year":"2014","unstructured":"Nara M, Komatsuda A, Omokawa A, Togashi M, Okuyama S, Sawada K, et al. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Mod Rheumatol. 2014;24(4):633\u20136.","journal-title":"Mod Rheumatol"},{"issue":"8","key":"3415_CR30","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.4049\/jimmunol.169.8.4288","volume":"169","author":"YC Liao","year":"2002","unstructured":"Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol. 2002;169(8):4288\u201397.","journal-title":"J Immunol"},{"issue":"1","key":"3415_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","volume":"6","author":"A Shimabukuro-Vornhagen","year":"2018","unstructured":"Shimabukuro-Vornhagen A, Godel P, Subklewe M, Stemmler HJ, Schlosser HA, Schlaak M, et al. Cytokine release syndrome. J Immunother Cancer. 2018;6(1):56.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"3415_CR32","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.24936","volume":"60","author":"H Bilgic","year":"2009","unstructured":"Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, et al. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009;60(11):3436\u201346.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3415_CR33","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1002\/art.34659","volume":"64","author":"AM Reed","year":"2012","unstructured":"Reed AM, Peterson E, Bilgic H, Ytterberg SR, Amin S, Hein MS, et al. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum. 2012;64(12):4078\u201386.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3415_CR34","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1093\/rheumatology\/keaa906","volume":"60","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhou S, Wu C, Li M, Wang Q, Zhao Y, et al. Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis. Rheumatology (Oxford). 2021;60(7):e227\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3415_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/09546634.2018.1546043","volume":"30","author":"P Ciechanowicz","year":"2019","unstructured":"Ciechanowicz P, Rakowska A, Sikora M, Rudnicka L. JAK-inhibitors in dermatology: current evidence and future applications. J Dermatolog Treat. 2019;30(7):648\u201358.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"3415_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang X, Ye S. Tofacitinib in Amyopathic Dermatomyositis-Associated interstitial lung disease. N Engl J Med. 2019;381(3):291\u20133.","journal-title":"N Engl J Med"},{"issue":"12","key":"3415_CR37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3899\/jrheum.220367","volume":"49","author":"L Fan","year":"2022","unstructured":"Fan L, Lyu W, Liu H, Jiang H, Chen L, Liu Y, et al. A retrospective analysis of Outcome in Melanoma differentiation-Associated Gene 5-Related interstitial lung Disease treated with Tofacitinib or Tacrolimus. J Rheumatol. 2022;49(12):1356\u201364.","journal-title":"J Rheumatol"},{"issue":"12","key":"3415_CR38","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1093\/rheumatology\/keaa266","volume":"59","author":"W Huang","year":"2020","unstructured":"Huang W, Ren F, Luo L, Zhou J, Huang D, Pan Z, et al. The characteristics of lymphocytes in patients positive for anti-MDA5 antibodies in interstitial lung disease. Rheumatology (Oxford). 2020;59(12):3886\u201391.","journal-title":"Rheumatology (Oxford)"},{"key":"3415_CR39","doi-asserted-by":"publisher","first-page":"845988","DOI":"10.3389\/fimmu.2022.845988","volume":"13","author":"Y Zuo","year":"2022","unstructured":"Zuo Y, Ye L, Chen F, Shen Y, Lu X, Wang G, et al. Different multivariable risk factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 positive dermatomyositis and anti-synthetase syndrome. Front Immunol. 2022;13:845988.","journal-title":"Front Immunol"},{"issue":"1","key":"3415_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12890-023-02706-y","volume":"23","author":"FP Ren","year":"2023","unstructured":"Ren FP, Chen Q, Yao SS, Feng L, Xue XY, Zhao WC, et al. Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease. BMC Pulm Med. 2023;23(1):411.","journal-title":"BMC Pulm Med"},{"issue":"10","key":"3415_CR41","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2006-06-027599","volume":"108","author":"E Kamphuis","year":"2006","unstructured":"Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood. 2006;108(10):3253\u201361.","journal-title":"Blood"},{"key":"3415_CR42","doi-asserted-by":"publisher","first-page":"103232","DOI":"10.1016\/j.jaut.2024.103232","volume":"146","author":"B Huang","year":"2024","unstructured":"Huang B, Li H, Jiang Q, Li Y, Jiang Z, Cao H, et al. Elevated type I IFN signalling directly affects CD8(+) T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients. J Autoimmun. 2024;146:103232.","journal-title":"J Autoimmun"},{"issue":"1","key":"3415_CR43","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1038\/s41467-022-34145-4","volume":"13","author":"Y Ye","year":"2022","unstructured":"Ye Y, Chen Z, Jiang S, Jia F, Li T, Lu X, et al. Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5\u2009+\u2009dermatomyositis with therapeutic implications. Nat Commun. 2022;13(1):6458.","journal-title":"Nat Commun"},{"key":"3415_CR44","doi-asserted-by":"publisher","first-page":"808875","DOI":"10.3389\/fmed.2021.808875","volume":"8","author":"X Lv","year":"2021","unstructured":"Lv X, Jin Y, Zhang D, Li Y, Fu Y, Wang S, et al. Low circulating Monocytes is in parallel with Lymphopenia which predicts poor outcome in anti-melanoma differentiation-Associated Gene 5 antibody-positive Dermatomyositis-Associated interstitial lung disease. Front Med (Lausanne). 2021;8:808875.","journal-title":"Front Med (Lausanne)"},{"key":"3415_CR45","doi-asserted-by":"crossref","unstructured":"Chen X, Jiang W, Jin Q, Peng Q, Zhang L, Lin S, et al. Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease. RMD Open. 2023;9(2):e003150.","DOI":"10.1136\/rmdopen-2023-003150"},{"issue":"16","key":"3415_CR46","doi-asserted-by":"publisher","first-page":"e2313070121","DOI":"10.1073\/pnas.2313070121","volume":"121","author":"Y Ichimura","year":"2024","unstructured":"Ichimura Y, Konishi R, Shobo M, Tanaka R, Kubota N, Kayama H, et al. Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice. Proc Natl Acad Sci U S A. 2024;121(16):e2313070121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3415_CR47","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","volume":"38","author":"F Saito","year":"2008","unstructured":"Saito F, Tasaka S, Inoue K, Miyamoto K, Nakano Y, Ogawa Y, et al. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol. 2008;38(5):566\u201371.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"3415_CR48","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1038\/s41598-017-13511-z","volume":"7","author":"EA Ayaub","year":"2017","unstructured":"Ayaub EA, Dubey A, Imani J, Botelho F, Kolb MRJ, Richards CD, et al. Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis. Sci Rep. 2017;7(1):13281.","journal-title":"Sci Rep"},{"issue":"4","key":"3415_CR49","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1165\/rcmb.2002-0262OC","volume":"29","author":"YP Moodley","year":"2003","unstructured":"Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, Laurent GJ, et al. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol. 2003;29(4):490\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3415_CR50","doi-asserted-by":"publisher","first-page":"1151695","DOI":"10.3389\/fimmu.2023.1151695","volume":"14","author":"J Qian","year":"2023","unstructured":"Qian J, Li R, Chen Z, Cao Z, Lu L, Fu Q. Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients. Front Immunol. 2023;14:1151695.","journal-title":"Front Immunol"},{"issue":"1","key":"3415_CR51","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1038\/s41467-020-18854-2","volume":"11","author":"R Nienhold","year":"2020","unstructured":"Nienhold R, Ciani Y, Koelzer VH, Tzankov A, Haslbauer JD, Menter T, et al. Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nat Commun. 2020;11(1):5086.","journal-title":"Nat Commun"},{"issue":"5","key":"3415_CR52","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/mr\/roac091","volume":"33","author":"S He","year":"2023","unstructured":"He S, Zhou Y, Fan C, Ma J, Chen Y, Wu W, et al. Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis. Mod Rheumatol. 2023;33(5):975\u201381.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"3415_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/14397595.2020.1740400","volume":"31","author":"K Yamaguchi","year":"2021","unstructured":"Yamaguchi K, Yamaguchi A, Onuki Y, Itai M, Kashiwagi C, Takehara K, et al. Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age. Mod Rheumatol. 2021;31(1):177\u201385.","journal-title":"Mod Rheumatol"},{"key":"3415_CR54","doi-asserted-by":"publisher","first-page":"1209282","DOI":"10.3389\/fimmu.2023.1209282","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, Zhao X, Liu B, Zhao Y, Li X, Ma Z, et al. Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Front Immunol. 2023;14:1209282.","journal-title":"Front Immunol"},{"issue":"12","key":"3415_CR55","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1348-0421.2012.00508.x","volume":"56","author":"X Xu","year":"2012","unstructured":"Xu X, Huang Q, Mao Y, Cui Z, Li Y, Huang Y, et al. Immunomodulatory effects of Bacillus subtilis (natto) B4 spores on murine macrophages. Microbiol Immunol. 2012;56(12):817\u201324.","journal-title":"Microbiol Immunol"},{"key":"3415_CR56","doi-asserted-by":"publisher","first-page":"678457","DOI":"10.3389\/fimmu.2021.678457","volume":"12","author":"A Kishore","year":"2021","unstructured":"Kishore A, Petrek M. Roles of macrophage polarization and macrophage-derived miRNAs in Pulmonary Fibrosis. Front Immunol. 2021;12:678457.","journal-title":"Front Immunol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03415-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T20:05:15Z","timestamp":1730145915000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03415-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3415"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03415-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of the First Affiliated Hospital of Sun Yat-sen University (ID: [2024]396).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}